Digital symptom management is shown to improve patients’ overall survival and quality of life.

Kaiku’s unique algorithms screen symptoms, alert care team and provide support for cancer patients. This along with the capture and analysis of real world data paves way for more personalised and value-based healthcare.

How it works

Kaiku Health is a digital health intervention platform for cancer clinics

Cancer immunotherapies

Modules for managing immune-related adverse events

There’s still limited knowledge on adverse events when treating patients with cancer immunotherapies. These adverse events may include the body’s own immune system attacking healthy tissues. We are actively working with leading centers in order to better understand and manage toxicities of Immune Checkpoint Inhibitor and CAR T Cell therapies.

Scientific evidence

Impact of digital patient monitoring

Overall survival

Studies show increased overall survival with patient-reported symptom monitoring compared to usual care.

A randomised controlled trial with 766 metastatic cancer patients shows that digital symptom monitoring during chemotherapy helps patients live longer (5.2 months longer median overall survival), improves quality of life (31% of patients), and reduces hospitalisation (4%) and ER visits (7%). (Basch & al. 2016–2017).

Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017 Jul 11; 318(2): 197–198.
PRO-monitoring vs. usual care

Patients' quality of life after 6 months

Patient-reported symptom monitoring
53% 29% 18%
Usual care
38% 28% 34%

ER visits and hospitalization at one year mark

Patient-reported symptom monitoring
Usual care
ER visits
34% 41%
45% 49%

Duration that patients remained in chemotherapy

Patient-reported symptom monitoring
Usual care
Months undergoing chemotherapy
8.2 6.3
Source: Basch E, Allison MD, Mark GK, Howard IS, Clifford AH, Paul S. Symptom Monitoring With Patient- Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial, J Clin Oncol 2016: 34(6), 557–565.

We are actively contributing to unveiling the value of digital symptom management and Patient-Reported Outcomes in routine cancer care.

Take a look at our pipeline


Kaiku Health is used for capturing and processing data in all common cancer types

Breast cancer

Prostate and other urological cancers

Lung cancer

Colorectal and other GI cancers

Hematologic cancers

Melanoma and other skin cancers

Gynecological cancers

Head and neck cancers

Compliant with all cancer care pathways

  • Surgery
  • Systemic therapies
  • Radiotherapy
  • Follow-up
  • Palliative care


Get in touch with us

Interested in learning more about Kaiku Health? Send us a note